Related references
Note: Only part of the references are listed.Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin
Fernando Cesar Bizerra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia
Nicholas D. Beyda et al.
CLINICAL INFECTIOUS DISEASES (2014)
Candida glabrata: a review of its features and resistance
C. F. Rodrigues et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Candida glabrata Intra-Abdominal Candidiasis Is Characterized by Persistence within the Peritoneal Cavity and Abscesses
Shaoji Cheng et al.
INFECTION AND IMMUNITY (2014)
Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)
Olivier Lortholary et al.
INTENSIVE CARE MEDICINE (2014)
Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities
Hilmar Wisplinghoff et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Time to Positivity and Detection of Growth in Anaerobic Blood Culture Vials Predict the Presence of Candida glabrata in Candidemia: a Two-Center European Cohort Study
Nazaret Cobos-Trigueros et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Breakthrough Invasive Candida glabrata in Patients on Micafungin: a Novel FKS Gene Conversion Correlated with Sequential Elevation of MIC
Takeshi Saraya et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Candidaemia Observed at a University Hospital in Milan (Northern Italy) and Review of Published Studies from 2010 to 2014
Laura Milazzo et al.
MYCOPATHOLOGIA (2014)
Prevalence of Candida nivariensis and Candida bracarensis in Vulvovaginal Candidiasis
Jianling Li et al.
MYCOPATHOLOGIA (2014)
Isavuconazole and Nine Comparator Antifungal Susceptibility Profiles for Common and Uncommon Candida Species Collected in 2012: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values
Mariana Castanheira et al.
MYCOPATHOLOGIA (2014)
Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure
James S. Lewis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Comparative genomics of emerging pathogens in the Candida glabrata clade
Toni Gabaldon et al.
BMC GENOMICS (2013)
Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
Barbara D. Alexander et al.
CLINICAL INFECTIOUS DISEASES (2013)
Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study
Gregory A. Eschenauer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Usefulness of time-to-positivity in aerobic and anaerobic vials to predict the presence of Candida glabrata in patients with candidaemia
Nazaret Cobos-Trigueros et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds
Michael A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Candida vaginitis in non-pregnant patients: A study of antifungal susceptibility testing and virulence factors
A. Kalkanci et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2013)
The epithelial adhesin 1 (Epa1p) from the human-pathogenic yeast Candida glabrata: structural and functional study of the carbohydrate-binding domain
Francesco S. Ielasi et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2012)
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
David R. Andes et al.
CLINICAL INFECTIOUS DISEASES (2012)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
O. A. Cornely et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients
M. Ruhnke et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
A scoring model of factors associated with Candida glabrata candidemia among critically ill patients
Gino G. Tapia et al.
MYCOSES (2012)
Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008)
Anna Maria Tortorano et al.
MYCOSES (2012)
Breakthrough Fungemia Due to Candida glabrata During Posaconazole Prophylaxis in Hematology Patients Treated with Anidulafungin - Report of 5 Cases
V. Krcmery et al.
JOURNAL OF CHEMOTHERAPY (2011)
Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia
Maiken Cavling Arendrup et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients
Yves Cohen et al.
CRITICAL CARE MEDICINE (2010)
Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry
David L. Horn et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Candida glabrata fungaemia: the importance of anaerobic blood culture
Mamie Hui et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents
Andrew M. Borman et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Correlation of the MIC and Dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia
Juan L. Rodriguez-Tudela et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2007)
Anidulafungin versus fluconazole for invasive candidiasis
Annette C. Reboli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
Ernst-Ruediger Kuse et al.
LANCET (2007)
Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia
Manjunath P. Pai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Candidemia in Norway (1991 to 2003):: Results from a nationwide study
P Sandven et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial
BJ Kullberg et al.
LANCET (2005)
A yeast by any other name:: Candida glabrata and its interaction with the host
R Kaur et al.
CURRENT OPINION IN MICROBIOLOGY (2005)
Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole
A Imhof et al.
CLINICAL INFECTIOUS DISEASES (2004)
Comparison of caspofungin and amphotericin B for invasive candidiasis.
J Mora-Duarte et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Breakthrough candidemia, in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity
DP Kontoyiannis et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2002)
Outcome in critically ill patients with candidal fungaemia:: Candida albicans vs. Candida glabrata
S Blot et al.
JOURNAL OF HOSPITAL INFECTION (2001)
Share Paper
